Implementation of misoprostol for postabortion care in Kenya and Uganda: A qualitative evaluation

Global Health Action

Volumn 6, Issue 1, 2013, Pages

  Osur, Joachim ^a   Baird, Traci L ^a   Levandowski, Brooke A ^a   Jackson, Emily ^b   Murokora, Daniel ^c  

^a IPAS   (United States)

^b Independent Practice   (United States)

^c Uganda Women's Health Initiative   (Uganda)

Author keywords

Implementation research; Misoprostol; Postabortion care

Indexed keywords

ABORTIVE AGENT; MISOPROSTOL;

AFTERCARE; ARTICLE; CLINICAL PROTOCOL; COUNSELING; FEMALE; HUMAN; IMPLEMENTATION RESEARCH; KENYA; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PATIENT EDUCATION; POSTABORTION CARE; PREGNANCY; UGANDA;

IMPLEMENTATION RESEARCH; MISOPROSTOL; POSTABORTION CARE;

ABORTIFACIENT AGENTS; AFTERCARE; CLINICAL PROTOCOLS; COUNSELING; FEMALE; HUMANS; KENYA; MISOPROSTOL; PATIENT EDUCATION AS TOPIC; PREGNANCY; UGANDA;

MLCS; MLOWN;

EID: 84880170047     PISSN: None     EISSN: 16549880     Source Type: Journal    
DOI: 10.3402/gha.v6i0.19649     Document Type: Article

References (40)

1. Grimes DA. Unsafe abortion: the silent scourge. Br Med Bull 2003; 67: 99-113.
2. Singh S, Wulf D, Hussain R, Bankole A, Sedgh G. Abortion worldwide: a decade of uneven progress. New York: Guttmacher Institute; 2009.
3. Sedgh G, Singh S, Shah I, Ahman E, Henshaw S, Bankole A. Induced abortion: incidence and trends worldwide from 1995 to 2008. Lancet 2012; 379: 625-32.
4. Kenya Penal Code. Sections 158-160, 214 and 240. Kenya; 1973.
5. Constitution of the Republic of Uganda. Part XIV(b), XX, articles 22.2, 27, 34(3) and 41. Uganda; 1995.
6. Kenya Constitution. Chapter 4 part 2 Art. 26(4). Kenya; 2010. Available from: http://www.kenyaembassy.com/pdfs/The%20Constitution%20of%20Kenya.pdf [cited 19 April 2012].
7. World Health Organization (2010). Trends in maternal mortality: 1990 to 2008. Geneva: WHO Press.
8. World Health Organization (2011). Unsafe abortion. Global and regional estimates of the incidence of unsafe abortion and associated mortality in 2008. 6th ed. Geneva: WHO Press.
9. Center for Reproductive Rights (2010). In harm's way: the impact of Kenya's restrictive abortion law. New York: Center for Reproductive Rights.
10. Singh S. Hospital admissions resulting from unsafe abortion: estimates from 13 developing countries. Lancet 2006; 368: 1887-92.
11. Postabortion Care Consortium Community Task Force (2002). Essential elements of postabortion care: an expanded and updated model. Postabortion Care Consortium.
12. World Health Organization (2012). Safe abortion: technical and policy guidance for health systems. Geneva: WHO Press.
13. Raghavan S, Bynum J, eds. Misoprostol for treatment of incomplete abortion: an introductory guidebook. New York: Gynuity; 2009.
14. Hofmeyr GJ, Gulmezoglu AM, Pileggi C. Vaginal misoprostol for cervical ripening and induction of labor. Cochrane Database Syst Rev 2010; Art. No.: CD000941. DOI: 10.1002/14651858. CD000941.pub2.
15. Gulmezoglu AM, Forna F, Villar J, Hofmeyr GJ. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2007; Art. No.: CD000494. DOI: 10.1002/14651858. CD000494.pub3.
16. Kapp N, Lohr PA, Ngo TD, Hayes JL. Cervical preparation for first trimester surgical abortion. Cochrance Database Syst Rev 2010; Art. No.: CD007207. DOI: 10.1002/14651858.CD007207. pub2.
17. Newmann SJ, Dalve-Endres A, Diedrich JT, Steinauer JE, Meckstroth K, Drey EA. Cervical preparation for second trimester dilation and evacuation. Cochrane Database Syst Rev 2010; Art. No.: CD007310. DOI: 10.1002/14651858.CD007 310.pub2.
18. Kulier R, Kapp N, Gulmezoglu AM, Hofmeyr GJ, Cheng L, Campana A. Medical methods for first trimester abortion. Cochrane Database Syst Rev 2011; Art. No.: CD002855. DOI: 10.1002/14651858.CD002855.pub4.
19. Wildschut H, Both MI, Medema S, Thomee E, Wildhagen MF, Kapp N. Medical methods for mid-trimester termination of pregnancy. Cochrane Database Syst Rev 2011; Art No.: CD 005216. DOI: 10.1002/14651858.CD005216.pub2.
20. Neilson JP, Gyte GM, Hickey M, Vazquez JC, Dou L. Medical treatments for incomplete miscarriage (less than 24 weeks). Cochrane Database Syst Rev 2010; Art. No.: CD007223. DOI: 10.1002/14651858.CD007223.pub2.
21. Clark W, Shannon C, WinikoffB. Misoprostol for uterine evacuation in induced abortion and pregnancy failure. Expet Rev Obstet Gynecol 2007; 2: 67-108.
22. Shwekerela B, Kalumuna R, Kipingili R, Mashaka N, Westheimer E, Clark W, et al. Misoprostol for treatment of incomplete abortion at the regional hospital level: results from Tanzania. BJOG 2007; 114: 1363-7.
23. Weeks A, Alia G, Blum J, WinikoffB, Ekwaru P, Durocher J, et al. A randomized trial of oral misoprostol versus manual vacuum aspiration for the treatment of incomplete abortion in Kampala, Uganda. Obstet Gynecol 2005; 106: 540-7.
24. Moreno-Ruiz NL, Borgatta L, Yanow S, Kapp N, Wiebe ER, WinikoffB. Alternatives to mifepristone for early medical abortion. Int J Gynaecol Obstet 2007; 96: 212-8.
25. Bique C, Usta M, Debora B, Chong E, Westheimer E, WinikoffB. Comparison of misoprostol and manual vacuum aspiration for the treatment of incomplete abortion. Int J Gynaecol Obstet 2007; 98: 222-6.
26. Dao B, Blum J, Thieba B, Raghavan S, Ouedraego M, Lankoande J, et al. Is misoprostol a safe, effective, acceptable alternative to manual vacuum aspiration for post abortion care? Results from a randomized trial in Burkina Faso, West Africa. BJOG 2007; 114: 1368-75.
27. Dah T, Akiode A, Awah P, Fetters T, Okoh M, Ujah I, et al. Introducing misoprostol for the treatment of incomplete abortion in Nigeria. Afr J Reprod Health 2011; 15: 42-50.
28. World Health Organization (2011). WHO model list of essential medicines. 17th List. Geneva: WHO Press.
29. World Health Organization (2009). WHO model list of essential medicines. 16th List. Geneva: WHO Press.
30. Ipas (2003). Service delivery point assessment tool for initiation of abortion related services. Chapel Hill: Ipas.
31. Ipas (2009). Misoprostol for management of incomplete and missed abortions: a clinical protocol. Chapel Hill: Ipas.
32. Pope C, Ziebland S, Mays N. Analysing qualitative data. BMJ 2000; 320: 114.
33. Uganda Ministry of Health (2008). Road map for reduction of maternal and neonatal death. Kampala, Uganda: Uganda Ministry of Health.
34. Uganda (2010). National Development Plan. Kampala, Uganda.
35. World Health Organization (2005). WHO model list of essential medicines. 14th List. Geneva: WHO Press.
36. Ministry of Medical Services and Ministry of Public Health and Sanitation (2010). Kenya essential medicines list 2010. Nairobi, Kenya: Ministry of Medical Services and Ministry of Public Health and Sanitation.
37. World Health Organization (2007). The WHO strategic approach to strengthening sexual and reproductive health policies and programmes. Geneva: WHO Press.
38. Shochet T, Diop A, Gaye A, Nayama M, Sall AB, Bukola F, et al. Sublingual misoprostol versus standard surgical care for treatment of incomplete abortion in five sub-Saharan African countries. BMC Pregnancy Childbirth 2012; 12: 127.
39. Uganda National Drug Authority (2011). Registration Number 6230/22/08: Misotac [Misoprostol 200mcg]. Kampala, Uganda: Uganda National Drug Authority.
40. Ipas (2011). Medical abortion supply guidance, forecasting tool. Chapel Hill: Ipas.